Search research articles
Contact Us
Filters
Showing results (161-170 of 173) with videos related to
Page
of 18
Sort By:
Cancer Letters
|
October 16, 2012
Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft models
Amit K Tiwari, Kamlesh Sodani, Chun-Ling Dai, et al.
Molecular Pharmacology
|
April 12, 2012
Neratinib reverses ATP-binding cassette B1-mediated chemotherapeutic drug resistance in vitro, in vivo, and ex vivo
Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, et al.
Plos One
|
January 26, 2013
BIRB796, the inhibitor of p38 mitogen-activated protein kinase, enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cells
Dan He, Xiao-qin Zhao, Xing-gui Chen, et al.
Cancer Research
|
March 16, 2011
Sildenafil reverses ABCB1- and ABCG2-mediated chemotherapeutic drug resistance
Zhi Shi, Amit K Tiwari, Suneet Shukla, et al.
Plos One
|
May 10, 2011
The phosphodiesterase-5 inhibitor vardenafil is a potent inhibitor of ABCB1/P-glycoprotein transporter
Pei-Rong Ding, Amit K Tiwari, Shinobu Ohnuma, et al.
Frontiers in Medicine
|
January 30, 2023
Prenatal arsenic exposure induces immunometabolic alteration and renal injury in rats
Radha Dutt Singh, Ratnakar Tiwari, Vineeta Sharma, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology
|
July 10, 2014
Interobserver variation is a significant limitation in the diagnosis of Burkitt lymphoma
Swapnil Ulhas Rane, Tanuja Shet, Epari Sridhar, et al.
Molecular Pharmaceutics
|
August 5, 2011
Blockade of Her2/neu binding to Hsp90 by emodin azide methyl anthraquinone derivative induces proteasomal degradation of Her2/neu
Yan-yan Yan, Li-sheng Zheng, Xu Zhang, et al.
Molecular Pharmaceutics
|
May 29, 2012
Enhancing chemosensitivity in ABCB1- and ABCG2-overexpressing cells and cancer stem-like cells by an Aurora kinase inhibitor CCT129202
Chao Cheng, Zhen-guo Liu, Hui Zhang, et al.
International Journal of Cancer
|
May 25, 2012
Saracatinib (AZD0530) is a potent modulator of ABCB1-mediated multidrug resistance in vitro and in vivo
Ke-Jun Liu, Jie-Hua He, Xiao-Dong Su, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 173) with videos related to
Sort By:
Page
of 18
Cancer Letters
|
October 16, 2012
Nilotinib potentiates anticancer drug sensitivity in murine ABCB1-, ABCG2-, and ABCC10-multidrug resistance xenograft models
Amit K Tiwari, Kamlesh Sodani, Chun-Ling Dai, et al.
Molecular Pharmacology
|
April 12, 2012
Neratinib reverses ATP-binding cassette B1-mediated chemotherapeutic drug resistance in vitro, in vivo, and ex vivo
Xiao-qin Zhao, Jing-dun Xie, Xing-gui Chen, et al.
Plos One
|
January 26, 2013
BIRB796, the inhibitor of p38 mitogen-activated protein kinase, enhances the efficacy of chemotherapeutic agents in ABCB1 overexpression cells
Dan He, Xiao-qin Zhao, Xing-gui Chen, et al.
Cancer Research
|
March 16, 2011
Sildenafil reverses ABCB1- and ABCG2-mediated chemotherapeutic drug resistance
Zhi Shi, Amit K Tiwari, Suneet Shukla, et al.
Plos One
|
May 10, 2011
The phosphodiesterase-5 inhibitor vardenafil is a potent inhibitor of ABCB1/P-glycoprotein transporter
Pei-Rong Ding, Amit K Tiwari, Shinobu Ohnuma, et al.
Frontiers in Medicine
|
January 30, 2023
Prenatal arsenic exposure induces immunometabolic alteration and renal injury in rats
Radha Dutt Singh, Ratnakar Tiwari, Vineeta Sharma, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology
|
July 10, 2014
Interobserver variation is a significant limitation in the diagnosis of Burkitt lymphoma
Swapnil Ulhas Rane, Tanuja Shet, Epari Sridhar, et al.
Molecular Pharmaceutics
|
August 5, 2011
Blockade of Her2/neu binding to Hsp90 by emodin azide methyl anthraquinone derivative induces proteasomal degradation of Her2/neu
Yan-yan Yan, Li-sheng Zheng, Xu Zhang, et al.
Molecular Pharmaceutics
|
May 29, 2012
Enhancing chemosensitivity in ABCB1- and ABCG2-overexpressing cells and cancer stem-like cells by an Aurora kinase inhibitor CCT129202
Chao Cheng, Zhen-guo Liu, Hui Zhang, et al.
International Journal of Cancer
|
May 25, 2012
Saracatinib (AZD0530) is a potent modulator of ABCB1-mediated multidrug resistance in vitro and in vivo
Ke-Jun Liu, Jie-Hua He, Xiao-Dong Su, et al.
Page
of 18